iTeos Therapeutics, Inc.

iTeos Therapeutics, Inc.verified

ITOS

Price:

$8.835

Market Cap:

$322.67M

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachuset...[Read more]

Industry

Biotechnology

IPO Date

2020-07-24

Stock Exchange

NASDAQ

Ticker

ITOS

The Dividend Yield as of November 2024 (TTM) for iTeos Therapeutics, Inc. (ITOS) is 0%

According to iTeos Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

iTeos Therapeutics, Inc. (ITOS) Historical Dividend Yield (quarterly & annually)

How has ITOS Dividend Yield performed in the past?

The mean historical Dividend Yield of iTeos Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), ITOS's Dividend Yield was at its highest in in the March 2019 quarter at 0%. The Dividend Yield was at its lowest in in the March 2019 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

iTeos Therapeutics, Inc. (ITOS) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of iTeos Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20230%0%
20220%0%
20210%0%
20200%0%
20190%0%

iTeos Therapeutics, Inc. (ITOS) Average Dividend Yield

How has ITOS Dividend Yield performed in the past?

The current Dividend Yield of iTeos Therapeutics, Inc. (ITOS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

iTeos Therapeutics, Inc. (ITOS) Dividend Yield vs. Peers

How is ITOS’s Dividend Yield compared to its peers?

iTeos Therapeutics, Inc.’s Dividend Yield is less than Icosavax, Inc. (0%), less than Mirati Therapeutics, Inc. (0%), less than VectivBio Holding AG (0%), less than Annexon, Inc. (0%), less than Gracell Biotechnologies Inc. (0%), less than Theseus Pharmaceuticals, Inc. (0%), less than Monte Rosa Therapeutics, Inc. (0%), less than Design Therapeutics, Inc. (0%), less than Erasca, Inc. (0%), less than Apellis Pharmaceuticals, Inc. (0%), less than TScan Therapeutics, Inc. (0%), less than Terns Pharmaceuticals, Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than Acumen Pharmaceuticals, Inc. (0%), less than Amylyx Pharmaceuticals, Inc. (0%), less than MoonLake Immunotherapeutics (0%), less than Revolution Medicines, Inc. (0%), less than Blueprint Medicines Corporation (0%), less than Sana Biotechnology, Inc. (0%), less than Kymera Therapeutics, Inc. (0%),

Build a custom stock screener for iTeos Therapeutics, Inc. (ITOS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like iTeos Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

iTeos Therapeutics, Inc. (ITOS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like iTeos Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is iTeos Therapeutics, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for iTeos Therapeutics, Inc. (ITOS)?

What is the highest Dividend Yield for iTeos Therapeutics, Inc. (ITOS)?

What is the 3-year average Dividend Yield for iTeos Therapeutics, Inc. (ITOS)?

What is the 5-year average Dividend Yield for iTeos Therapeutics, Inc. (ITOS)?

How does the current Dividend Yield for iTeos Therapeutics, Inc. (ITOS) compare to its historical average?